Pharmacoeconomic Evaluation of Linezolid Versus Teicoplanin in Bacteremia by Gram-Positive Microorganisms*

被引：0
|
作者：
Santiago Grau
Javier Mateu-de Antonio
Javier Soto
Mónica Marín-Casino
Esther Salas
机构：
[1] Hospital del Mar,Pharmacy Department
[2] Medical Unit,Pharmacoepidemiology and Pharmacoeconomics Department
来源：
Pharmacy World and Science | 2005年 / 27卷
关键词：
Cost-effectiveness analysis; Gram-positive bacteremia; Linezolid; Pharmacoeconomics; Teicoplanin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：459 / 464
页数：5
相关论文
共 50 条
  • [1] Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by gram-positive microorganisms
    Grau, S
    Mateu-de Antonio, J
    Soto, J
    Marín-Casino, M
    Salas, E
    PHARMACY WORLD & SCIENCE, 2005, 27 (06): : 459 - 464
  • [2] Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain
    Grau, S.
    Aguado, J. M.
    Antonio, J. Mateu-De
    Gonzalez, P.
    Del Castillo, A.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 398 - 409
  • [3] TEICOPLANIN - A PHARMACOECONOMIC EVALUATION OF ITS USE IN THE TREATMENT OF GRAM-POSITIVE INFECTIONS
    SPENCER, CM
    BRYSON, HM
    PHARMACOECONOMICS, 1995, 7 (04) : 357 - 374
  • [4] TEICOPLANIN IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA AND ENDOCARDITIS
    CRUCIANI, M
    CONCIA, E
    DIPERRI, G
    ADAMI, T
    NAVARRA, A
    FENDT, D
    DESTRO, G
    MARONE, P
    SOLBIATI, M
    BASSETTI, D
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (05): : 704 - 714
  • [5] VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER - REPLY
    ROLSTON, KVI
    ELTING, LS
    BODEY, GP
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05): : 1344 - 1345
  • [6] TEICOPLANIN IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN NEUTROPENIC PATIENTS
    MICOZZI, A
    VENDITTI, M
    AMADORI, S
    PULSONI, A
    TIRINDELLI, C
    MARTINO, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 : 19 - 23
  • [7] Linezolid Treatment for Gram-Positive Infections: A Retrospective Comparison with Teicoplanin
    Tascini, C.
    Gemignani, G.
    Doria, R.
    Biancofiore, G.
    Urbani, L.
    Mosca, C.
    Malacarne, P.
    Papineschi, F.
    Passaglia, C.
    Dal Canto, L.
    Procaccini, M.
    Furneri, G.
    Didoni, G.
    Filipponi, F.
    Menichetti, F.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (03) : 311 - 316
  • [8] Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
    Wilcox, M
    Nathwani, D
    Dryden, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) : 335 - 344
  • [9] Linezolid - A pharmacoeconomic review of its use in serious gram-positive infections
    Plosker, GL
    Figgitt, DP
    PHARMACOECONOMICS, 2005, 23 (09) : 945 - 964
  • [10] Linezolid vs vancomycin in children with resistant Gram-positive bacteremia
    Deville, JG
    Edge-Padbury, B
    Naberhuis-Stehouwer, S
    Bruss, JB
    PEDIATRIC RESEARCH, 2003, 53 (04) : 322A - 322A
12345